Rating Change
BTIG reiterated its Buy rating on AC Immune S.A. (NASDAQ:ACIU) on August 20, 2026.
reiterateNASDAQ:ACIU
BTIG Reiterates Buy Rating on AC Immune S.A. (ACIU)
BTIG reiterated its Buy rating on AC Immune S.A. (NASDAQ:ACIU) on August 20, 2026.
At publication ·
What changed
AC Immune S.A. (NASDAQ:ACIU) · reiterate
- Firm
- BTIG
- Rating
- Buy to Buy
- Price at event
- $2.64
- Market capitalization
- $294.8M
At a glance
Key takeaways
- BTIG reiterated its Buy rating on AC Immune S.A. (ACIU) on August 20, 2026, with the stock trading at $2.64 and a market capitalization of $294.8 million.
- All 10 of the most recent analyst ratings for ACIU are Buy ratings with no Hold or Sell ratings, indicating unanimous positive sentiment among recent coverage.
- BTIG has maintained a consistent Buy rating on ACIU across multiple rating dates from November 2025 through August 2026, showing sustained analyst conviction.
Market Context
AC Immune S.A. operates in the Healthcare sector. The stock currently trades at $2.64 with a market capitalization of $294.8M.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for AC Immune S.A.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for AC Immune S.A.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | BTIG | Buy | N/A |
| Aug 05, 2026 | BTIG | Buy | N/A |
| May 04, 2026 | BTIG | Buy | N/A |
| Mar 16, 2026 | BTIG | Buy | N/A |
| Nov 04, 2025 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ACIU Stock Page
Frequently Asked Questions
What does the Buy rating mean for ACIU?
A rating of Buy from BTIG reflects the analyst's outlook on AC Immune S.A. (NASDAQ:ACIU). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ACIU forecast page.